Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Novo Nordisk Warns of 1st Sales Drop Since Start of Ozempic

Digest more
Top News
Overview
Futurism · 6h
Novo Nordisk Furious at $49 Knockoff Ozempic Pill
Novo Nordisk vowed to take legal action against telehealth company Hims & Hers for selling a knockoff of its weight loss pill.

Continue reading

 · 2d
Novo Nordisk Warns of First Sales Drop Since Start of Ozempic
 · 2d · on MSN
Novo Nordisk stock extends losses as Ozempic maker sees sales falling in 2026
 · 2d
Novo Nordisk plunge wipes $50 billion off obesity drug giant
Feb 4 (Reuters) - Novo Nordisk (NOVOb.CO) shares tumbled 16% on Wednesday, wiping off around $50 billion from the Wegovy maker's market capitalization after it warned on Tuesday its sales and profits ...

Continue reading

 · 2d
Sales Warning Slams Ozempic Maker Novo Nordisk's Stock
 · 2d
Novo Nordisk Stock Extends Losses as Ozempic Maker Sees Sales Falling in 2026
1d

New Ozempic Ads Feature ‘Get A Mac’ Duo Justin Long And John Hodgman

Novo Nordisk brought in Justin Long and John Hodgman, who had been in the Apple "Get A Mac" ads from 20 years ago, to star in the new "Only One Ozempic" commercials.
2don MSN

Novo to launch Ozempic pill for diabetes in second quarter of 2026

Feb 4 (Reuters) - Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said the U.
7d

Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic

Lawsuit claims Novo Nordisk delayed generic Victoza using patent tactics and settlements, preserving monopoly pricing and shifting demand to Ozempic.
5hon MSN

Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore

The market for obesity drugs may soon reach almost $100 billion.
2d

Eli Lilly Stock Soars While Novo Nordisk Sinks—Why the Weight-Loss Leaders Are Headed in Opposite Directions

Eli Lilly's stock surged Wednesday while shares of weight-loss rival Novo Nordisk slumped, widening the gap between the drugmakers.
Medical Marketing & Media
17d

Ozempic pays homage to an iconic Apple ad with new spots featuring Justin Long and John Hodgman

Novo Nordisk developed There’s Only One Ozempic in partnership with Rogue Producer, an independent advertising and content production department.
1don MSN

Wegovy pill in high demand in weeks since launch, Novo Nordisk says

Novo Nordisk said Wednesday that demand for its Wegovy pill got off to a strong start after it launched in the U.S. in early January
  • Privacy
  • Terms